Fox Chase and Weill Cornell Medicine selected as founding members of NCI prevention initiative - The Cancer Letter

1 year ago 35

Fox Chase Cancer Center and Weill Cornell Medicine were selected to make a caller Cancer Prevention-Interception Targeted Agent Discovery Program. 

To entree this subscriber-only contented delight log successful oregon renew your subscription.

Looking for IP Login? Our IP Login strategy is present automatic. If your instauration has a site license, delight log successful from connected tract oregon via your VPN to entree this content.

Login Subscribe

Jaya M. Satagopan, PhD, is simply a afloat subordinate successful the Cancer Prevention and Control Program astatine Rutgers Cancer Institute of New Jersey and prof successful the section of Biostatistics and Epidemiology astatine the Rutgers School of Public Health. Between 2016 and 2019, Dr. Satagopan completed her Master’s grade successful subject connection and nationalist engagement from the University of Edinburgh.

Selina M. Luger, a hematologist-oncologist and acute leukemia and myeloid disorders researcher, was appointed seat of the ECOG-ACRIN Cancer Research Group Leukemia Committee. 

The James P. Allison Institute astatine MD Anderson Cancer Center established an interior advisory assembly to supply technological input and to align the enactment of the institute with the broader MD Anderson probe enterprise.

Candel Therapeutics Inc., a clinical-stage biopharmaceutical institution processing viral immunotherapies, formed a collaboration with the University of Pennsylvania to survey the interaction of caller viral immunotherapies based connected Candel’s proprietary enLIGHTEN Discovery Platform to fortify the effects of Penn’s CAR-T compartment therapies successful coagulated tumor models.

The Max Foundation, the ABC Global Alliance, the American Society of Clinical Pathology, Cepheid, and Novartis AG are joining and committing resources to amended outcomes for radical surviving with HR+/HER2- precocious bosom attraction successful low- and middle-income countries.

Researchers astatine UT Southwestern reported successful the diary Nature Cancer that Talzenna (talazoparib) successfully shrank the tumors of bosom crab patients with mutations successful the PALB2 gene. 

Read Entire Article